Development of Biomaterials for Bone Tissue Engineering Based on Bile Acids

Overview

Journal J Mater Sci Mater Med

Publisher Springer

Date 2025 Jan 15

PMID 39812871

Authors

Yongjun Liu

Xiaojie Liu

Chang Liu

Wenan Zhang

Ting Shi

Guanying Liu

Affiliations

Soon will be listed here.

Abstract

Diseases and injuries can cause significant bone loss, leading to increased medical expenses, decreased work efficiency, and a decline in quality of life. Bone tissue engineering (BTE) is gaining attention as an alternative to autologous and allogeneic transplantation due to the limited availability of donors. Biomaterials represent a promising strategy for bone regeneration, and their design should consider the three key processes in bone tissue engineering: osteogenesis, bone conduction, and bone induction. Certain bile acids (BAs) demonstrate significant antioxidant, anti-inflammatory, and immunosuppressive properties, and effectively promote bone and tissue regeneration. Additionally, the combination of BA molecule with other biological materials can help overcome problems associated with limited local bone regeneration and maintain a defined release state for a long time. Thus in this review, we focus on the role and the mechanism of bile acids in bone healing under different conditions, highlighting their unique properties and applications in gel fabrication, microencapsulation, and nanotechnology. These advancements serve as a basis for the advancement of biomaterials derived from BAs, specifically for the purpose of bone reconstruction.

References

Wang P, Zhao L, Liu J, Weir M, Zhou X, Xu H . Bone tissue engineering via nanostructured calcium phosphate biomaterials and stem cells. Bone Res. 2015; 2:14017. PMC: 4472121. DOI: 10.1038/boneres.2014.17. View

Bonucci E . Bone mineralization. Front Biosci (Landmark Ed). 2011; 17(1):100-28. DOI: 10.2741/3918. View

Das S, de Rooy S, Jordan A, Chandler L, Negulescu I, El-Zahab B . Tunable size and spectral properties of fluorescent nanoGUMBOS in modified sodium deoxycholate hydrogels. Langmuir. 2011; 28(1):757-65. PMC: 3336216. DOI: 10.1021/la2027016. View

Mohsen A, Hasanein Asfour M, Salama A . Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes. Drug Dev Ind Pharm. 2017; 43(12):2043-2054. DOI: 10.1080/03639045.2017.1361968. View

Zimmermann E, Ritchie R . Bone as a Structural Material. Adv Healthc Mater. 2015; 4(9):1287-304. DOI: 10.1002/adhm.201500070. View

Vandooren J, Van den Steen P, Opdenakker G . Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Crit Rev Biochem Mol Biol. 2013; 48(3):222-72. DOI: 10.3109/10409238.2013.770819. View

de Carvalho R, Casarin R, de Lima P, Cogo-Muller K . Statins with potential to control periodontitis: From biological mechanisms to clinical studies. J Oral Biosci. 2021; 63(3):232-244. DOI: 10.1016/j.job.2021.06.002. View

Mooranian A, Ionescu C, Wagle S, Kovacevic B, Walker D, Jones M . Chenodeoxycholic Acid Pharmacology in Biotechnology and Transplantable Pharmaceutical Applications for Tissue Delivery: An Acute Preclinical Study. Cells. 2021; 10(9). PMC: 8472107. DOI: 10.3390/cells10092437. View

Kundu S, Bansal S, Muthukumarasamy K, Sachidanandan C, Motiani R, Bajaj A . Deciphering the role of hydrophobic and hydrophilic bile acids in angiogenesis using and model systems. Medchemcomm. 2018; 8(12):2248-2257. PMC: 6071941. DOI: 10.1039/c7md00475c. View

10.

Ying J, Dai S, Fu R, Hong J, Dai C, Jin Q . Effect of ursodeoxycholic acid on gallstone formation after bariatric surgery: An updated meta-analysis. Obesity (Silver Spring). 2022; 30(6):1170-1180. DOI: 10.1002/oby.23427. View

11.

Ahmad J, Singhal M, Amin S, Rizwanullah M, Akhter S, Kamal M . Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides. Curr Pharm Des. 2017; 23(11):1575-1588. DOI: 10.2174/1381612823666170124111142. View

12.

Negrulj R, Mooranian A, Chen-Tan N, Al-Sallami H, Mikov M, Golocorbin-Kon S . Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes. Artif Cells Nanomed Biotechnol. 2015; 44(5):1290-7. DOI: 10.3109/21691401.2015.1024845. View

13.

Jurado S, Pares A, Peris P, Combalia A, Monegal A, Guanabens N . Bilirubin increases viability and decreases osteoclast apoptosis contributing to osteoporosis in advanced liver diseases. Bone. 2022; 162:116483. DOI: 10.1016/j.bone.2022.116483. View

14.

Jeon O, Seo D, Kim H, Byun Y, Park J . Oral delivery of zoledronic acid by non-covalent conjugation with lysine-deoxycholic acid: In vitro characterization and in vivo anti-osteoporotic efficacy in ovariectomized rats. Eur J Pharm Sci. 2015; 82:1-10. DOI: 10.1016/j.ejps.2015.11.004. View

15.

Mooranian A, Negrulj R, Takechi R, Jamieson E, Morahan G, Al-Salami H . Alginate-combined cholic acid increased insulin secretion of microencapsulated mouse cloned pancreatic β cells. Ther Deliv. 2017; 8(10):833-842. DOI: 10.4155/tde-2017-0042. View

16.

Cho S, An J, Park H, Yang J, Choi H, Kim S . Positive regulation of osteogenesis by bile acid through FXR. J Bone Miner Res. 2013; 28(10):2109-21. DOI: 10.1002/jbmr.1961. View

17.

Manohar S, Das C, Kakati V . Bone Tissue Engineering Scaffolds: Materials and Methods. 3D Print Addit Manuf. 2024; 11(1):347-362. PMC: 10880649. DOI: 10.1089/3dp.2022.0216. View

18.

Xia Y, Mei F, Duan Y, Gao Y, Xiong Z, Zhang T . Bone tissue engineering using bone marrow stromal cells and an injectable sodium alginate/gelatin scaffold. J Biomed Mater Res A. 2012; 100(4):1044-50. DOI: 10.1002/jbm.a.33232. View

19.

Chavez-Talavera O, Tailleux A, Lefebvre P, Staels B . Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. Gastroenterology. 2017; 152(7):1679-1694.e3. DOI: 10.1053/j.gastro.2017.01.055. View

20.

Ruiz-Gaspa S, Guanabens N, Enjuanes A, Peris P, Martinez-Ferrer A, Martinez de Osaba M . Lithocholic acid downregulates vitamin D effects in human osteoblasts. Eur J Clin Invest. 2010; 40(1):25-34. DOI: 10.1111/j.1365-2362.2009.02230.x. View